Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nature's answer to Ferroptosis: how bioactive compounds rewire oxidative stress circuits in cerebral ischemia. | Int Immunopharmacol | 2025 | 40706206 | PubTator, text mining | PubMed |
| Targeting BACH1/PSPH axis suppresses bladder cancer progression and gemcitabine resistance by downregulating S100A2 expression. | Biochem Pharmacol | 2025 | 40684997 | PubTator, text mining | PubMed |
| Genome-wide rules of transcription factor cooperativity revealed through in silico binding site ablation. | bioRxiv | 2025 | 40667078 | PubTator, text mining | PubMed |
| CCNY-mediated phosphorylation and TET2-BACH1-driven DNA demethylation activate PRC1 to augment NSCLC progression. | J Exp Clin Cancer Res | 2025 | 40665337 | PubTator, text mining | PubMed |
| Transcriptional programs underlying human monocyte differentiation and diversity. | J Leukoc Biol | 2025 | 40631795 | PubTator, text mining | PubMed |
| Transcriptional regulation of cuproptosis resistance in cancer therapy. | Trends Cancer | 2025 | 40571556 | PubTator, text mining | PubMed |
| Harnessing Antioxidants in Cancer Therapy: Opportunities, Challenges, and Future Directions. | Antioxidants (Basel) | 2025 | 40563308 | PubTator, text mining | PubMed |
| FUNCTIONAL ANALYSIS OF BIPARTITE NRF2 ACTIVATORS THAT OVERCOME FEEDBACK REGULATION FOR AGE-RELATED CHRONIC DISEASES. | bioRxiv | 2025 | 40501562 | PubTator, text mining | PubMed |
| Mechanism by which the molecular glue-like verteporfin induces IRE1α dimerization and activation to synergize with AKT inhibition in breast cancer. | Cell Chem Biol | 2025 | 40472846 | PubTator, text mining | PubMed |
| Impaired airway epithelial miR-155/BACH1/NRF2 axis and hypoxia gene expression during RSV infection in children with down syndrome. | Front Pediatr | 2025 | 40469089 | PubTator, text mining | PubMed |
| Heshuxiaoji pill suppresses steatohepatitis and fibrosis by regulating the AngII-BACH1 mediated vasoconstriction. | J Ethnopharmacol | 2025 | 40383247 | PubTator, text mining | PubMed |
| MiR-155 overexpression regulates Th1/Th2 balance by inhibiting BACH1 to activate Nrf-2/HO-1 signaling pathway in allergic rhinitis. | Arch Biochem Biophys | 2025 | 40339975 | PubTator, text mining | PubMed |
| Transcription factor BACH1 promotes epithelial-mesenchymal transition by repressing iron metabolism-related genes. | Biochem Biophys Res Commun | 2025 | 40315568 | PubTator, text mining | PubMed |
| Targeting prominin-2/BACH1/GLS pathway to inhibit oxidative stress-induced ferroptosis of bone mesenchymal stem cells. | Stem Cell Res Ther | 2025 | 40301995 | PubTator, text mining | PubMed |
| Single-cell epigenetics and multiomics analysis in kidney research. | Clin Exp Nephrol | 2025 | 40281349 | PubTator, text mining | PubMed |
| Closing the gap: Nonviral TFAMoplex transfection boosted by bZIP domains compared to AAV-mediated transduction. | Mol Ther Nucleic Acids | 2025 | 40276698 | PubTator, text mining | PubMed |
| SDCBP/Syntenin-1 stabilizes BACH1 by disassembling the SCFFBXO22-BACH1 complex in triple-negative breast cancer. | EMBO J | 2025 | 40263598 | PubTator, text mining | PubMed |
| ATF4:p52 complex activates oncogenic enhancers in multiple myeloma via p300/CBP recruitment to regulate BACH1. | Cancer Lett | 2025 | 40250789 | PubTator, text mining | PubMed |
| Molecular and Immunometabolic Landscape of Erythrophagocytosis-induced Ferroptosis. | Cardiovasc Hematol Disord Drug Targets | 2025 | 40231500 | PubTator, text mining | PubMed |
| Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. | Cancer Cell | 2025 | 40215978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=7